Location History:
- Sugar Land, TX (US) (2022)
- Houston, TX (US) (2022)
Company Filing History:
Years Active: 2022
Title: Monique Nilsson: Innovator in Cancer Treatment
Introduction
Monique Nilsson is a prominent inventor based in Sugar Land, Texas, known for her significant contributions to cancer treatment research. With a focus on developing innovative compounds, she has been instrumental in advancing therapies for patients with specific genetic mutations.
Latest Patents
Monique holds two patents that showcase her groundbreaking work. The first patent, titled "Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations," provides methods for treating cancer in patients with these mutations by administering third-generation tyrosine kinase inhibitors, such as poziotinib or afatinib. The second patent, "Heterocyclic inhibitors of tyrosine kinase," relates to heterocyclic compounds and methods that may serve as inhibitors of HER2 or EGFR, aimed at treating or preventing diseases, including cancer.
Career Highlights
Monique is affiliated with the University of Texas System, where she continues to push the boundaries of cancer research. Her work has garnered attention for its potential to improve treatment outcomes for patients with challenging cancer types.
Collaborations
Monique collaborates with esteemed colleagues, including John V Heymach and Jacqulyne Robichaux, to further enhance the impact of her research. Their combined expertise contributes to the development of innovative solutions in the field of oncology.
Conclusion
Monique Nilsson's contributions to cancer treatment through her patents and research collaborations highlight her role as a leading inventor in the medical field. Her work continues to inspire advancements in therapies for patients facing difficult diagnoses.